Sanara Medtech Inc (SMTI)

Currency in USD
24.76
+0.60(+2.48%)
Closed·
After Hours
24.760.00(0.00%)
·
SMTI Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected in 8 days
Fair Value
Day's Range
24.0125.08
52 wk Range
23.5339.08
Key Statistics
Prev. Close
24.76
Open
24.31
Day's Range
24.01-25.08
52 wk Range
23.53-39.08
Volume
46.61K
Average Volume (3m)
43.08K
1-Year Change
-13.73%
Book Value / Share
4.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SMTI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
49.00
Upside
+97.90%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Sanara Medtech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Sanara Medtech Inc Company Profile

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Employees
141

Sanara Medtech Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue grew 26% YoY to $23.4M, missing $24.1M forecast; EPS of -$0.41 missed -$0.265 estimate
  • Net loss of $3.5M reported; gross margin improved 240 bps to 92%; adjusted EBITDA up 111% YoY to $700,000
  • Stock fell 1% premarket to $34.75; CEO remains optimistic about 'large greenfield opportunity' despite earnings miss
  • Company faces profitability challenges; executives emphasize long-term vision and early stage of commercialization efforts
  • Analysts focused on distributor network expansion and surgeon adoption strategies during Q&A session
Last Updated: 14/05/2025, 13:52
Read Full Transcript

Compare SMTI to Peers and Sector

Metrics to compare
SMTI
Peers
Sector
Relationship
P/E Ratio
−19.3x−3.0x−0.5x
PEG Ratio
0.15−0.130.00
Price/Book
6.0x2.7x2.6x
Price / LTM Sales
2.4x3.2x3.3x
Upside (Analyst Target)
97.9%12.8%43.5%
Fair Value Upside
Unlock3.5%6.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 49.00
(+97.90% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.41 / -0.27
Revenue / Forecast
23.40M / 24.10M
EPS Revisions
Last 90 days

SMTI Income Statement

People Also Watch

92.40
ZBH
+1.96%
76.41
OKLO
+6.88%
48.81
NVO
+1.29%
22.44
BAX
+2.19%
18.69
CAG
+0.97%

FAQ

What Stock Exchange Does Sanara Medtech Trade On?

Sanara Medtech is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sanara Medtech?

The stock symbol for Sanara Medtech is "SMTI."

What Is the Sanara Medtech Market Cap?

As of today, Sanara Medtech market cap is 220.06M.

What Is Sanara Medtech's Earnings Per Share (TTM)?

The Sanara Medtech EPS (TTM) is -1.34.

When Is the Next Sanara Medtech Earnings Date?

Sanara Medtech will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is SMTI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sanara Medtech Stock Split?

Sanara Medtech has split 2 times.

How Many Employees Does Sanara Medtech Have?

Sanara Medtech has 141 employees.

What is the current trading status of Sanara Medtech (SMTI)?

As of 05 Aug 2025, Sanara Medtech (SMTI) is trading at a price of 24.76, with a previous close of 24.76. The stock has fluctuated within a day range of 24.01 to 25.08, while its 52-week range spans from 23.53 to 39.08.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.